Surgery Partners: Riding the Outpatient Surgery Boom, But Debt Reduction is the Key to Unlocking Value
Overview
Surgery Partners stands as a leading national provider of outpatient surgical solutions, boasting a comprehensive network of ambulatory surgery centers, surgical hospitals, and specialty practices. Its differentiated, partnership-oriented business model aligns incentives with physicians and health systems, delivering high-quality, cost-effective care. The investment thesis is anchored in the secular tailwind moving surgical procedures from costly inpatient settings to more efficient outpatient environments—further amplified by disciplined acquisitions and the opening of new facilities. However, this growth has come at the cost of significant leverage, making deleveraging and portfolio optimization the central catalysts for future shareholder value. With a probability-weighted five-year price target of $44.75 versus a current price of $22.51, the report rates SGRY a Buy for long-term investors willing to embrace balance sheet-driven risks.